For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

You are here

Publications

Found 71 results
Author Title Type [ Year(Asc)]
Filters: Author is Ma, Xiaojing  [Clear All Filters]
2005
Murray HW, Flanders KC, Donaldson DD, Sypek JP, Gotwals PJ, Liu J, Ma X.  2005.  Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.. Infect Immun. 73(7):3903-11.
Torroella-Kouri M, Ma X, Perry G, Ivanova M, Cejas PJ, Owen JL, Iragavarapu-Charyulu V, Lopez DM.  2005.  Diminished expression of transcription factors nuclear factor kappaB and CCAAT/enhancer binding protein underlies a novel tumor evasion mechanism affecting macrophages of mammary tumor-bearing mice.. Cancer Res. 65(22):10578-84.
Kim S, Chung EY, Ma X.  2005.  Immunological consequences of macrophage-mediated clearance of apoptotic cells.. Cell Cycle. 4(2):231-4.
Liu J, Guan X, Ma X.  2005.  Interferon regulatory factor 1 is an essential and direct transcriptional activator for interferon {gamma}-induced RANTES/CCl5 expression in macrophages.. J Biol Chem. 280(26):24347-55.
Liu J, Cao S, Kim S, Chung EY, Homma Y, Guan X, Jimenez V, Ma X.  2005.  Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression.. Curr Immunol Rev. 1(2):119-137.
Cao S, Liu J, Song L, Ma X.  2005.  The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages.. J Immunol. 174(6):3484-92.
Shan D, Chen L, Njardarson JT, Gaul C, Ma X, Danishefsky SJ, Huang X-Y.  2005.  Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice.. Proc Natl Acad Sci U S A. 102(10):3772-6.
2004
Luo Q, Ma X, Wahl SM, Bieker JJ, Crossley M, Montaner LJ.  2004.  Activation and repression of interleukin-12 p40 transcription by erythroid Kruppel-like factor in macrophages.. J Biol Chem. 279(18):18451-6.
Shi X, Liu J, Xiang Z, Mitsuhashi M, Wu RS, Ma X.  2004.  Gene expression analysis in Interleukin-12-induced suppression of mouse mammary carcinoma.. Int J Cancer. 110(4):570-8.
Shi X, Cao S, Mitsuhashi M, Xiang Z, Ma X.  2004.  Genome-wide analysis of molecular changes in IL-12-induced control of mammary carcinoma via IFN-gamma-independent mechanisms.. J Immunol. 172(7):4111-22.
Cao S, Xiang Z, Ma X.  2004.  Global gene expression profiling in interleukin-12-induced activation of CD8(+) cytotoxic T lymphocytes against mouse mammary Carcinoma.. Cell Mol Immunol. 1(5):357-66.
Mitsuhashi M, Liu J, Cao S, Shi X, Ma X.  2004.  Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas.. J Leukoc Biol. 76(2):322-32.
Liu J, Xiang Z, Ma X.  2004.  Role of IFN regulatory factor-1 and IL-12 in immunological resistance to pathogenesis of N-methyl-N-nitrosourea-induced T lymphoma.. J Immunol. 173(2):1184-93.
Liu J, Guan X, Tamura T, Ozato K, Ma X.  2004.  Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein.. J Biol Chem. 279(53):55609-17.
Kim S, Elkon KB, Ma X.  2004.  Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells.. Immunity. 21(5):643-53.